Literature DB >> 7029987

Hyperinsulinemia in patients with low fractional catabolic rate of triglycerides.

U Julius, W Leonhardt, J Schulze, K Schollberg, M Hanefeld, H Haller.   

Abstract

In non-diabetic persons whose serum triglyceride (TG) concentrations ranged from normal to very high levels, endogenous TG turnover was measured using the radioglycerol method of Farquhar and coworkers. Insulin, FFA, and glucose concentrations were estimated during an oral glucose tolerance test. Stimulated insulin levels were correlated positively to TG concentrations and absolute TG turnover rates, and negatively to fractional TG catabolic rates. FFA concentrations had similar relationships, also in non-insulin-dependent diabetics. A more detailed analysis showed that elevated insulin and FFA levels - as an expression of peripheral insulin resistance - are typical finding in the kind of patients whose fractional TG catabolic rate is low [less than or equal to 0.210 (h-1)], irrespective of actual serum TG concentration. Our data do not suggest a stimulatory role of insulin for TG production.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7029987     DOI: 10.1007/bf02047893

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  15 in total

1.  VALIDATION OF AN INCOMPLETELY COUPLED TWO-COMPARTMENT NONRECYCLING CATENARY MODEL FOR TURNOVER OF LIVER AND PLASMA TRIGLYCERIDE IN MAN.

Authors:  J W FARQUHAR; R C GROSS; R M WAGNER; G M REAVEN
Journal:  J Lipid Res       Date:  1965-01       Impact factor: 5.922

2.  Effect of obesity on the relationship between very low density lipoprotein production rate and plasma triglyceride concentration in normal and hypertriglyceridemic subjects.

Authors:  G M Reaven; R M Bernstein
Journal:  Metabolism       Date:  1978-09       Impact factor: 8.694

3.  Reappraisal of the role of insulin in hypertriglyceridemia.

Authors:  J M Olefsky; J W Farquhar; G M Reaven
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

4.  Polymorphism of plasma triglyceride kinetics in normal human adult subjects.

Authors:  E A Nikkilä; M Kekki
Journal:  Acta Med Scand       Date:  1971 Jul-Aug

5.  Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia.

Authors:  J D Bagdade; E L Bierman; D Porte
Journal:  Diabetes       Date:  1971-10       Impact factor: 9.461

6.  [Methodical studies and directions for the measurement of fatty acid curves in capillary blood].

Authors:  W Leonhardt; H Haller; M Hanefeld; R Paukert; I Tauscher
Journal:  Z Med Labortech       Date:  1970

7.  Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects.

Authors:  L A Zech; S M Grundy; D Steinberg; M Berman
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

8.  Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia.

Authors:  Y Maruhama; R Abe; F Okuguchi; S Oikawa; A Ohneda; Y Goto
Journal:  Diabetes       Date:  1978-06       Impact factor: 9.461

9.  Regulation of endogenous plasma triglyceride concentration: can we measure the rate of production or of removal of endogenous plasma triglycerides in man?

Authors:  L A Carlson
Journal:  Eur J Clin Invest       Date:  1980-02       Impact factor: 4.686

10.  Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man.

Authors:  A H Kissebah; S Alfarsi; P W Adams; V Wynn
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

View more
  2 in total

Review 1.  Androgen receptor (AR) in cardiovascular diseases.

Authors:  Chiung-Kuei Huang; Soo Ok Lee; Eugene Chang; Haiyan Pang; Chawnshang Chang
Journal:  J Endocrinol       Date:  2016-01-14       Impact factor: 4.286

Review 2.  Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria.

Authors:  Alexander Panov; Vladimir I Mayorov; Sergey Dikalov
Journal:  Int J Mol Sci       Date:  2022-04-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.